Log in
Enquire now
JARDIANCE

JARDIANCE

(empagliflozin) tablets

OverviewStructured DataIssuesContributors

Contents

jardiance.com
Is a
Product
Product

Product attributes

Industry
Medicine
Medicine
Product Parent Company
Boehringer Ingelheim
Boehringer Ingelheim

JARDIANCE is a prescription medicine used to:

  • lower blood sugar along with diet and exercise in adults with type 2 diabetes
  • reduce the risk of cardiovascular death in adults with type 2 diabetes who also have known cardiovascular disease
  • reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure, when the heart cannot pump enough blood to the rest of your body

JARDIANCE is not for people with type 1 diabetes. It may increase their risk of diabetic ketoacidosis (increased ketones in the blood or urine).

JARDIANCE is not for use to lower blood sugar in adults with type 2 diabetes who have severe kidney problems, because it may not work.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like JARDIANCE

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.